CT预测胰腺癌新辅助治疗后切缘阴性切除:系统评价与Meta分析
该系统评价与Meta分析纳入6项研究,评估新辅助治疗后CT判断可切除性预测胰腺导管腺癌R0切除的诊断准确性。普通标准敏感度45%、特异度85%,扩展标准敏感度81%、特异度42%,两种标准诊断准确性差异有统计学意义(p=0.02)。
要点
- 普通标准(仅可切除PDAC)预测R0切除敏感度45%、特异度85%。
- 扩展标准(可切除+临界可切除)敏感度81%、特异度42%。
- 两种标准诊断准确性差异有统计学意义(p=0.02),提示选择手术候选者需谨慎。
核心结论
- 普通标准预测R0切除可能高特异度但低敏感度,扩展标准提高敏感度但降低特异度。
- 两种标准的CT可切除性判断诊断性能均欠佳,作者建议新辅助治疗后选择手术候选者和确定手术范围时应谨慎。
- 作者认为使用定量参数可能改善R0切除的识别。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、EMBASE和Cochrane数据库至2020年2月24日。
- 初检739项研究,最终纳入6项研究(普通标准6项、扩展标准5项)。
- 纳入标准为能获取新辅助治疗后CT判断可切除性预测R0切除的敏感度和特异度、并以病理切缘状态为参考标准的研究。
- 按R0可切除肿瘤标准分为两组:普通标准(仅可切除PDAC)和扩展标准(可切除及临界可切除PDAC)。
诊断标准与关键数值
- 普通标准:汇总敏感度45%(95%CI 19-73%,I²=88.3%),汇总特异度85%(95%CI 65-94%,I²=60.5%)。
- 扩展标准:汇总敏感度81%(95%CI 71-87%,I²=0.0%),汇总特异度42%(95%CI 28-57%,I²=6.2%)。
- 两种标准诊断准确性差异有统计学意义(p=0.02)。
- 采用双变量随机效应模型分别估计各标准的汇总敏感度和特异度,并用联合模型双变量Meta回归比较两种标准。
临床应用与阅片要点
- 普通标准判断可切除时预测R0切除特异度高但敏感度低,可能漏判可R0切除的病例。
- 扩展标准提高敏感度但降低特异度,可能将不可R0切除的病例误判为可切除。
- 作者建议新辅助治疗后选择手术候选者和确定手术范围时应谨慎。
- 作者认为使用定量参数可能改善R0切除的识别。
局限性
- 普通标准汇总敏感度异质性I²=88.3%,特异度异质性I²=60.5%。
- 作者结论指出需进一步研究(Further investigations using quantitative parameters may improve the identification of R0 resection)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to systematically evaluate the diagnostic accuracy of CT-determined resectability following neoadjuvant treatment for predicting margin-negative resection (R0 resection) in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS: Original studies with sufficient details to obtain the sensitivity and specificity of CT-determined resectability following neoadjuvant treatment, with a reference on the pathological margin status, were identified in PubMed, EMBASE, and Cochrane databases until February 24, 2020. The identified studies were divided into two groups based on the criteria of R0 resectable tumor (ordinary criterion: resectable PDAC alone; extended criterion: resectable and borderline resectable PDAC). The meta-analytic summary of the sensitivity and specificity for each criterion was estimated separately using a bivariate random-effect model. Summary results of the two criteria were compared using a joint-model bivariate meta-regression.
RESULTS: Of 739 studies initially searched, 6 studies (6 with ordinary criterion and 5 with extended criterion) were included for analysis. The meta-analytic summary of sensitivity and specificity was 45% (95% confidence interval [CI], 19-73%; I2 = 88.3%) and 85% (95% CI, 65-94%; I2 = 60.5%) for the ordinary criterion, and 81% (95% CI, 71-87%; I2 = 0.0%) and 42% (95% CI, 28-57%; I2 = 6.2%) for the extended criterion, respectively. The diagnostic accuracy significantly differed between the two criteria (p = 0.02).
CONCLUSIONS: For determining resectability on CT, the ordinary criterion might be highly specific but insensitive for predicting R0 resection, whereas the extended criterion increased sensitivity but would decrease specificity. Further investigations using quantitative parameters may improve the identification of R0 resection.
KEY POINTS: • CT-determined resectability of PDAC after neoadjuvant treatment using the ordinary criterion shows low sensitivity and high specificity in predicting R0 resection. • With the extended criterion, CT-determined resectability shows higher sensitivity but lower specificity than with the ordinary criterion. • CT-determined resectability with both criteria achieved suboptimal diagnostic performances, suggesting that care should be taken while selecting surgical candidates and when determining the surgical extent after neoadjuvant treatment in patients with PDAC.
引用
- Park S, Jang JK, Byun JH, et al. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis. Eur Radiol. 2020. PMID: 33123793. doi:10.1007/s00330-020-07433-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。